Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss a control study

As of July 2012, a visit to the National Library of Medicine’s search engine, PubMed, revealed 497 research articles concerning AIED disease published since 1964 with eleven of these published in the last year. In spite of this moderate effort by the medical research community, AIED disease remains a chronic, incurable disorder that causes progressive disability to both hearing and balance. At the American Hearing Research Foundation (AHRF) , we have funded basic research on similar disorders in the past , and are interested in funding research on AIED in the future. We are particularly interested in projects that might lead to methods of stopping progression of hearing loss and the disabling attacks of dizziness. Get more information about contributing to the AHRF’s efforts to detect and treat acoustic neuroma.

      Initially majority of patients will respond to lifestyle interventions and a trial of betahistines for three months

Intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss a control study

intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss a control study

Media:

intratympanic steroid treatment in idiopathic sudden sensorineural hearing loss a control studyintratympanic steroid treatment in idiopathic sudden sensorineural hearing loss a control studyintratympanic steroid treatment in idiopathic sudden sensorineural hearing loss a control studyintratympanic steroid treatment in idiopathic sudden sensorineural hearing loss a control studyintratympanic steroid treatment in idiopathic sudden sensorineural hearing loss a control study